EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Down 38.5% in July

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 24,493 shares, a decrease of 38.5% from the June 30th total of 39,841 shares. Based on an average daily trading volume, of 180,734 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

EssilorLuxottica Price Performance

EssilorLuxottica stock traded up $0.54 during trading hours on Friday, reaching $95.14. 382,817 shares of the stock were exchanged, compared to its average volume of 118,704. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17. EssilorLuxottica has a 52-week low of $91.44 and a 52-week high of $186.81. The firm’s 50 day moving average is $98.30 and its 200 day moving average is $117.16.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on ESLOY shares. The Goldman Sachs Group downgraded shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They set a “hold” rating for the company. Finally, Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.